Search

Displaying results 4431 - 4440 of 7452 in total
  1. Drug

    Terameprocol

    go.drugbank.com/drugs/DB12226
    Investigational

    Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

  2. Drug

    Fenamole

    go.drugbank.com/drugs/DB12506
    Investigational

    Fenamole has been investigated for the supportive care of Side Effects and Dental Plaque.

  3. Drug

    MG98

    go.drugbank.com/drugs/DB06544
    Experimental

    MG98, a second-generation antisense oligodeoxynucleotide inhibitor of human DNMT1, was investigated in the completed clinical trial NCT00003890 for treating patients with advanced solid tumors.

  4. Drug

    Larazotide

    go.drugbank.com/drugs/DB05645
    Investigational

    An octapeptide inhibitor of paracellular permeability whose structure is derived from a protein (zonula occludens toxin) secreted by Vibrio cholerae for treatment of Coeliac disease.

  5. Drug

    Phenylbutyric acid

    go.drugbank.com/drugs/DB06819
    ApprovedInvestigational

    Phenylbutyric acid is a fatty acid and a derivative of butyric acid naturally produced by colonic bacteria fermentation. It demonstrates a number of cellular and biological effects, such as relieving inflammation and acting as a chemical...

  6. Drug

    Sulfaperin

    go.drugbank.com/drugs/DB13320
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  7. Drug

    Sulfametomidine

    go.drugbank.com/drugs/DB13485
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  8. Drug

    Chenopodium album pollen

    go.drugbank.com/drugs/DB10368
    Approved

    Chenopodium album pollen is the pollen of the Chenopodium album plant. Chenopodium album pollen is mainly used in allergenic testing.

    Mixtures: Number Four Weed Mixture
  9. Drug

    Rolapitant

    go.drugbank.com/drugs/DB09291
    ApprovedInvestigational

    Rolapitant is a potent, highly selective, long-acting Neurokinin-1 (NK-1) receptor antagonist approved for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in adults.

  10. Drug

    Mitiglinide

    go.drugbank.com/drugs/DB01252
    Investigational

    Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.